|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3508502 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18209399.7 |
| Date of filing the European patent application | 2014-09-18 | |
| (97) | Date of publication of the European application | 2019-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-26 |
| (46) | Date of publication of the claims translation | 2023-07-10 |
| (30) | Number | Date | Country code |
| 201361880606 P | 2013-09-20 | US | |
| 201462014471 P | 2014-06-19 | US |
| (72) |
KORMAN, Alan J. , US
LONBERG, Nils , US
FONTANA, David J. , US
GUTIERREZ, Andres A. , US
SELBY, Mark J. , US
LEWIS, Katherine E. , US
|
| (73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-LAG-3 antikūnų ir anti-PD-1 antikūnų derinys, skirtas navikų gydymui |
| COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS |
| Payment date | Validity (years) | Amount | |
| 2025-08-25 | 12 | 289.00 EUR |
| 2026-09-18 |